Global Infectious Diseases Molecular Diagnostics Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Infectious Diseases Molecular Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
The Infectious Diseases Molecular Diagnostics market is driven by the need for rapid and accurate diagnostics for infectious diseases and the increasing global incidence of such diseases. Molecular diagnostics offer advanced methods for detecting infectious pathogens and monitoring their genetic variations. The rise in emerging infectious diseases and the demand for point-of-care testing contribute to market growth as healthcare systems seek reliable tools for early detection and effective disease management. Moreover, advancements in diagnostic technologies, including nucleic acid amplification techniques and multiplex assays, align with improved sensitivity and specificity of infectious disease diagnosis. However, the market also faces challenges, including establishing standardized testing protocols and addressing cost barriers for widespread adoption. Additionally, ensuring accessibility and navigating regulatory approvals for new diagnostics can pose obstacles for manufacturers. To succeed, stakeholders must focus on developing innovative molecular diagnostic solutions, collaborating with public health agencies, and addressing the challenges to meet the increasing demand for rapid and accurate detection of infectious diseases.
LPI (LP Information)' newest research report, the “Infectious Diseases Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world Infectious Diseases Molecular Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Diseases Molecular Diagnostics sales for 2025 through 2031. With Infectious Diseases Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Diseases Molecular Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Infectious Diseases Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Diseases Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Diseases Molecular Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Diseases Molecular Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Diseases Molecular Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Diseases Molecular Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Infectious Diseases Molecular Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
The Infectious Diseases Molecular Diagnostics market is driven by the need for rapid and accurate diagnostics for infectious diseases and the increasing global incidence of such diseases. Molecular diagnostics offer advanced methods for detecting infectious pathogens and monitoring their genetic variations. The rise in emerging infectious diseases and the demand for point-of-care testing contribute to market growth as healthcare systems seek reliable tools for early detection and effective disease management. Moreover, advancements in diagnostic technologies, including nucleic acid amplification techniques and multiplex assays, align with improved sensitivity and specificity of infectious disease diagnosis. However, the market also faces challenges, including establishing standardized testing protocols and addressing cost barriers for widespread adoption. Additionally, ensuring accessibility and navigating regulatory approvals for new diagnostics can pose obstacles for manufacturers. To succeed, stakeholders must focus on developing innovative molecular diagnostic solutions, collaborating with public health agencies, and addressing the challenges to meet the increasing demand for rapid and accurate detection of infectious diseases.
LPI (LP Information)' newest research report, the “Infectious Diseases Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world Infectious Diseases Molecular Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Diseases Molecular Diagnostics sales for 2025 through 2031. With Infectious Diseases Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Diseases Molecular Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Infectious Diseases Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Diseases Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Diseases Molecular Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Diseases Molecular Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Diseases Molecular Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Diseases Molecular Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Polymerase Chain Reaction PCR
- Molecular Hybridization
- Biochip
- Others
- Hospital
- Third-party Testing Agency
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Qiagen
- Illumina
- Abbott
- Hologic
- BioMerieux
- Danaher (Cepheid)
- Myriad Genetics
- DAAN Gene
- Agilent
- Genomic Health
- BD
- Foundation Medicine
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Diseases Molecular Diagnostics Market Size (2020-2031)
2.1.2 Infectious Diseases Molecular Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Infectious Diseases Molecular Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Infectious Diseases Molecular Diagnostics Segment by Type
2.2.1 Polymerase Chain Reaction PCR
2.2.2 Molecular Hybridization
2.2.3 Biochip
2.2.4 Others
2.3 Infectious Diseases Molecular Diagnostics Market Size by Type
2.3.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Infectious Diseases Molecular Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Third-party Testing Agency
2.4.3 Others
2.5 Infectious Diseases Molecular Diagnostics Market Size by Application
2.5.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
3 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Infectious Diseases Molecular Diagnostics Market Size Market Share by Player
3.1.1 Global Infectious Diseases Molecular Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Infectious Diseases Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS BY REGION
4.1 Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025)
4.2 Global Infectious Diseases Molecular Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Diseases Molecular Diagnostics Market Size Growth (2020-2025)
4.4 APAC Infectious Diseases Molecular Diagnostics Market Size Growth (2020-2025)
4.5 Europe Infectious Diseases Molecular Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025)
5.2 Americas Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025)
5.3 Americas Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025)
6.2 APAC Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025)
6.3 APAC Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025)
7.2 Europe Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025)
7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Diseases Molecular Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET FORECAST
10.1 Global Infectious Diseases Molecular Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Infectious Diseases Molecular Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Infectious Diseases Molecular Diagnostics Forecast
10.1.3 APAC Infectious Diseases Molecular Diagnostics Forecast
10.1.4 Europe Infectious Diseases Molecular Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast
10.2 Americas Infectious Diseases Molecular Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Infectious Diseases Molecular Diagnostics Forecast
10.2.2 Canada Market Infectious Diseases Molecular Diagnostics Forecast
10.2.3 Mexico Market Infectious Diseases Molecular Diagnostics Forecast
10.2.4 Brazil Market Infectious Diseases Molecular Diagnostics Forecast
10.3 APAC Infectious Diseases Molecular Diagnostics Forecast by Region (2026-2031)
10.3.1 China Infectious Diseases Molecular Diagnostics Market Forecast
10.3.2 Japan Market Infectious Diseases Molecular Diagnostics Forecast
10.3.3 Korea Market Infectious Diseases Molecular Diagnostics Forecast
10.3.4 Southeast Asia Market Infectious Diseases Molecular Diagnostics Forecast
10.3.5 India Market Infectious Diseases Molecular Diagnostics Forecast
10.3.6 Australia Market Infectious Diseases Molecular Diagnostics Forecast
10.4 Europe Infectious Diseases Molecular Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Infectious Diseases Molecular Diagnostics Forecast
10.4.2 France Market Infectious Diseases Molecular Diagnostics Forecast
10.4.3 UK Market Infectious Diseases Molecular Diagnostics Forecast
10.4.4 Italy Market Infectious Diseases Molecular Diagnostics Forecast
10.4.5 Russia Market Infectious Diseases Molecular Diagnostics Forecast
10.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Infectious Diseases Molecular Diagnostics Forecast
10.5.2 South Africa Market Infectious Diseases Molecular Diagnostics Forecast
10.5.3 Israel Market Infectious Diseases Molecular Diagnostics Forecast
10.5.4 Turkey Market Infectious Diseases Molecular Diagnostics Forecast
10.6 Global Infectious Diseases Molecular Diagnostics Forecast by Type (2026-2031)
10.7 Global Infectious Diseases Molecular Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Infectious Diseases Molecular Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Infectious Diseases Molecular Diagnostics Product Offered
11.1.3 Roche Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Infectious Diseases Molecular Diagnostics Product Offered
11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Infectious Diseases Molecular Diagnostics Product Offered
11.3.3 Illumina Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Infectious Diseases Molecular Diagnostics Product Offered
11.4.3 Abbott Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Abbott Main Business Overview
11.4.5 Abbott Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Infectious Diseases Molecular Diagnostics Product Offered
11.5.3 Hologic Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Product Offered
11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Danaher (Cepheid)
11.7.1 Danaher (Cepheid) Company Information
11.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offered
11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Danaher (Cepheid) Main Business Overview
11.7.5 Danaher (Cepheid) Latest Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Information
11.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offered
11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Myriad Genetics Main Business Overview
11.8.5 Myriad Genetics Latest Developments
11.9 DAAN Gene
11.9.1 DAAN Gene Company Information
11.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Product Offered
11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 DAAN Gene Main Business Overview
11.9.5 DAAN Gene Latest Developments
11.10 Agilent
11.10.1 Agilent Company Information
11.10.2 Agilent Infectious Diseases Molecular Diagnostics Product Offered
11.10.3 Agilent Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Agilent Main Business Overview
11.10.5 Agilent Latest Developments
11.11 Genomic Health
11.11.1 Genomic Health Company Information
11.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Product Offered
11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Genomic Health Main Business Overview
11.11.5 Genomic Health Latest Developments
11.12 BD
11.12.1 BD Company Information
11.12.2 BD Infectious Diseases Molecular Diagnostics Product Offered
11.12.3 BD Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 BD Main Business Overview
11.12.5 BD Latest Developments
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Information
11.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offered
11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Foundation Medicine Main Business Overview
11.13.5 Foundation Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Diseases Molecular Diagnostics Market Size (2020-2031)
2.1.2 Infectious Diseases Molecular Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Infectious Diseases Molecular Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Infectious Diseases Molecular Diagnostics Segment by Type
2.2.1 Polymerase Chain Reaction PCR
2.2.2 Molecular Hybridization
2.2.3 Biochip
2.2.4 Others
2.3 Infectious Diseases Molecular Diagnostics Market Size by Type
2.3.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Infectious Diseases Molecular Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Third-party Testing Agency
2.4.3 Others
2.5 Infectious Diseases Molecular Diagnostics Market Size by Application
2.5.1 Infectious Diseases Molecular Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
3 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Infectious Diseases Molecular Diagnostics Market Size Market Share by Player
3.1.1 Global Infectious Diseases Molecular Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Infectious Diseases Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS BY REGION
4.1 Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025)
4.2 Global Infectious Diseases Molecular Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Diseases Molecular Diagnostics Market Size Growth (2020-2025)
4.4 APAC Infectious Diseases Molecular Diagnostics Market Size Growth (2020-2025)
4.5 Europe Infectious Diseases Molecular Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025)
5.2 Americas Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025)
5.3 Americas Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025)
6.2 APAC Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025)
6.3 APAC Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025)
7.2 Europe Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025)
7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Diseases Molecular Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET FORECAST
10.1 Global Infectious Diseases Molecular Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Infectious Diseases Molecular Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Infectious Diseases Molecular Diagnostics Forecast
10.1.3 APAC Infectious Diseases Molecular Diagnostics Forecast
10.1.4 Europe Infectious Diseases Molecular Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast
10.2 Americas Infectious Diseases Molecular Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Infectious Diseases Molecular Diagnostics Forecast
10.2.2 Canada Market Infectious Diseases Molecular Diagnostics Forecast
10.2.3 Mexico Market Infectious Diseases Molecular Diagnostics Forecast
10.2.4 Brazil Market Infectious Diseases Molecular Diagnostics Forecast
10.3 APAC Infectious Diseases Molecular Diagnostics Forecast by Region (2026-2031)
10.3.1 China Infectious Diseases Molecular Diagnostics Market Forecast
10.3.2 Japan Market Infectious Diseases Molecular Diagnostics Forecast
10.3.3 Korea Market Infectious Diseases Molecular Diagnostics Forecast
10.3.4 Southeast Asia Market Infectious Diseases Molecular Diagnostics Forecast
10.3.5 India Market Infectious Diseases Molecular Diagnostics Forecast
10.3.6 Australia Market Infectious Diseases Molecular Diagnostics Forecast
10.4 Europe Infectious Diseases Molecular Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Infectious Diseases Molecular Diagnostics Forecast
10.4.2 France Market Infectious Diseases Molecular Diagnostics Forecast
10.4.3 UK Market Infectious Diseases Molecular Diagnostics Forecast
10.4.4 Italy Market Infectious Diseases Molecular Diagnostics Forecast
10.4.5 Russia Market Infectious Diseases Molecular Diagnostics Forecast
10.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Infectious Diseases Molecular Diagnostics Forecast
10.5.2 South Africa Market Infectious Diseases Molecular Diagnostics Forecast
10.5.3 Israel Market Infectious Diseases Molecular Diagnostics Forecast
10.5.4 Turkey Market Infectious Diseases Molecular Diagnostics Forecast
10.6 Global Infectious Diseases Molecular Diagnostics Forecast by Type (2026-2031)
10.7 Global Infectious Diseases Molecular Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Infectious Diseases Molecular Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Infectious Diseases Molecular Diagnostics Product Offered
11.1.3 Roche Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Infectious Diseases Molecular Diagnostics Product Offered
11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Infectious Diseases Molecular Diagnostics Product Offered
11.3.3 Illumina Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Infectious Diseases Molecular Diagnostics Product Offered
11.4.3 Abbott Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Abbott Main Business Overview
11.4.5 Abbott Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Infectious Diseases Molecular Diagnostics Product Offered
11.5.3 Hologic Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Product Offered
11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Danaher (Cepheid)
11.7.1 Danaher (Cepheid) Company Information
11.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offered
11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Danaher (Cepheid) Main Business Overview
11.7.5 Danaher (Cepheid) Latest Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Information
11.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offered
11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Myriad Genetics Main Business Overview
11.8.5 Myriad Genetics Latest Developments
11.9 DAAN Gene
11.9.1 DAAN Gene Company Information
11.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Product Offered
11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 DAAN Gene Main Business Overview
11.9.5 DAAN Gene Latest Developments
11.10 Agilent
11.10.1 Agilent Company Information
11.10.2 Agilent Infectious Diseases Molecular Diagnostics Product Offered
11.10.3 Agilent Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Agilent Main Business Overview
11.10.5 Agilent Latest Developments
11.11 Genomic Health
11.11.1 Genomic Health Company Information
11.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Product Offered
11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Genomic Health Main Business Overview
11.11.5 Genomic Health Latest Developments
11.12 BD
11.12.1 BD Company Information
11.12.2 BD Infectious Diseases Molecular Diagnostics Product Offered
11.12.3 BD Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 BD Main Business Overview
11.12.5 BD Latest Developments
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Information
11.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offered
11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Foundation Medicine Main Business Overview
11.13.5 Foundation Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infectious Diseases Molecular Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Infectious Diseases Molecular Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Polymerase Chain Reaction PCR
Table 4. Major Players of Molecular Hybridization
Table 5. Major Players of Biochip
Table 6. Major Players of Others
Table 7. Infectious Diseases Molecular Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Table 10. Infectious Diseases Molecular Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Table 13. Global Infectious Diseases Molecular Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player (2020-2025)
Table 15. Infectious Diseases Molecular Diagnostics Key Players Head office and Products Offered
Table 16. Infectious Diseases Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Table 21. Global Infectious Diseases Molecular Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Country (2020-2025)
Table 25. Americas Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Table 27. Americas Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Table 29. APAC Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Table 31. APAC Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country (2020-2025)
Table 35. Europe Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Infectious Diseases Molecular Diagnostics
Table 41. Key Market Challenges & Risks of Infectious Diseases Molecular Diagnostics
Table 42. Key Industry Trends of Infectious Diseases Molecular Diagnostics
Table 43. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Roche Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 48. Roche Infectious Diseases Molecular Diagnostics Product Offered
Table 49. Roche Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Roche Main Business
Table 51. Roche Latest Developments
Table 52. Qiagen Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 53. Qiagen Infectious Diseases Molecular Diagnostics Product Offered
Table 54. Qiagen Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Qiagen Main Business
Table 56. Qiagen Latest Developments
Table 57. Illumina Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 58. Illumina Infectious Diseases Molecular Diagnostics Product Offered
Table 59. Illumina Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Illumina Main Business
Table 61. Illumina Latest Developments
Table 62. Abbott Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 63. Abbott Infectious Diseases Molecular Diagnostics Product Offered
Table 64. Abbott Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Abbott Main Business
Table 66. Abbott Latest Developments
Table 67. Hologic Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 68. Hologic Infectious Diseases Molecular Diagnostics Product Offered
Table 69. Hologic Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Hologic Main Business
Table 71. Hologic Latest Developments
Table 72. BioMerieux Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 73. BioMerieux Infectious Diseases Molecular Diagnostics Product Offered
Table 74. BioMerieux Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. BioMerieux Main Business
Table 76. BioMerieux Latest Developments
Table 77. Danaher (Cepheid) Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 78. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offered
Table 79. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Danaher (Cepheid) Main Business
Table 81. Danaher (Cepheid) Latest Developments
Table 82. Myriad Genetics Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 83. Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offered
Table 84. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Myriad Genetics Main Business
Table 86. Myriad Genetics Latest Developments
Table 87. DAAN Gene Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 88. DAAN Gene Infectious Diseases Molecular Diagnostics Product Offered
Table 89. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. DAAN Gene Main Business
Table 91. DAAN Gene Latest Developments
Table 92. Agilent Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 93. Agilent Infectious Diseases Molecular Diagnostics Product Offered
Table 94. Agilent Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Agilent Main Business
Table 96. Agilent Latest Developments
Table 97. Genomic Health Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 98. Genomic Health Infectious Diseases Molecular Diagnostics Product Offered
Table 99. Genomic Health Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Genomic Health Main Business
Table 101. Genomic Health Latest Developments
Table 102. BD Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 103. BD Infectious Diseases Molecular Diagnostics Product Offered
Table 104. BD Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. BD Main Business
Table 106. BD Latest Developments
Table 107. Foundation Medicine Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 108. Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offered
Table 109. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Foundation Medicine Main Business
Table 111. Foundation Medicine Latest Developments
Table 1. Infectious Diseases Molecular Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Infectious Diseases Molecular Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Polymerase Chain Reaction PCR
Table 4. Major Players of Molecular Hybridization
Table 5. Major Players of Biochip
Table 6. Major Players of Others
Table 7. Infectious Diseases Molecular Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Table 10. Infectious Diseases Molecular Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Table 13. Global Infectious Diseases Molecular Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player (2020-2025)
Table 15. Infectious Diseases Molecular Diagnostics Key Players Head office and Products Offered
Table 16. Infectious Diseases Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Table 21. Global Infectious Diseases Molecular Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Country (2020-2025)
Table 25. Americas Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Table 27. Americas Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Table 29. APAC Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Table 31. APAC Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country (2020-2025)
Table 35. Europe Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Infectious Diseases Molecular Diagnostics
Table 41. Key Market Challenges & Risks of Infectious Diseases Molecular Diagnostics
Table 42. Key Industry Trends of Infectious Diseases Molecular Diagnostics
Table 43. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Infectious Diseases Molecular Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Roche Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 48. Roche Infectious Diseases Molecular Diagnostics Product Offered
Table 49. Roche Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Roche Main Business
Table 51. Roche Latest Developments
Table 52. Qiagen Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 53. Qiagen Infectious Diseases Molecular Diagnostics Product Offered
Table 54. Qiagen Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Qiagen Main Business
Table 56. Qiagen Latest Developments
Table 57. Illumina Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 58. Illumina Infectious Diseases Molecular Diagnostics Product Offered
Table 59. Illumina Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Illumina Main Business
Table 61. Illumina Latest Developments
Table 62. Abbott Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 63. Abbott Infectious Diseases Molecular Diagnostics Product Offered
Table 64. Abbott Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Abbott Main Business
Table 66. Abbott Latest Developments
Table 67. Hologic Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 68. Hologic Infectious Diseases Molecular Diagnostics Product Offered
Table 69. Hologic Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Hologic Main Business
Table 71. Hologic Latest Developments
Table 72. BioMerieux Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 73. BioMerieux Infectious Diseases Molecular Diagnostics Product Offered
Table 74. BioMerieux Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. BioMerieux Main Business
Table 76. BioMerieux Latest Developments
Table 77. Danaher (Cepheid) Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 78. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offered
Table 79. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Danaher (Cepheid) Main Business
Table 81. Danaher (Cepheid) Latest Developments
Table 82. Myriad Genetics Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 83. Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offered
Table 84. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Myriad Genetics Main Business
Table 86. Myriad Genetics Latest Developments
Table 87. DAAN Gene Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 88. DAAN Gene Infectious Diseases Molecular Diagnostics Product Offered
Table 89. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. DAAN Gene Main Business
Table 91. DAAN Gene Latest Developments
Table 92. Agilent Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 93. Agilent Infectious Diseases Molecular Diagnostics Product Offered
Table 94. Agilent Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Agilent Main Business
Table 96. Agilent Latest Developments
Table 97. Genomic Health Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 98. Genomic Health Infectious Diseases Molecular Diagnostics Product Offered
Table 99. Genomic Health Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Genomic Health Main Business
Table 101. Genomic Health Latest Developments
Table 102. BD Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 103. BD Infectious Diseases Molecular Diagnostics Product Offered
Table 104. BD Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. BD Main Business
Table 106. BD Latest Developments
Table 107. Foundation Medicine Details, Company Type, Infectious Diseases Molecular Diagnostics Area Served and Its Competitors
Table 108. Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offered
Table 109. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Foundation Medicine Main Business
Table 111. Foundation Medicine Latest Developments
LIST OF FIGURES
Figure 1. Infectious Diseases Molecular Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Infectious Diseases Molecular Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Infectious Diseases Molecular Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Infectious Diseases Molecular Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type in 2024
Figure 10. Infectious Diseases Molecular Diagnostics in Hospital
Figure 11. Global Infectious Diseases Molecular Diagnostics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Infectious Diseases Molecular Diagnostics in Third-party Testing Agency
Figure 13. Global Infectious Diseases Molecular Diagnostics Market: Third-party Testing Agency (2020-2025) & ($ millions)
Figure 14. Infectious Diseases Molecular Diagnostics in Others
Figure 15. Global Infectious Diseases Molecular Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2024
Figure 17. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player in 2024
Figure 18. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Infectious Diseases Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. APAC Infectious Diseases Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Europe Infectious Diseases Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Americas Infectious Diseases Molecular Diagnostics Value Market Share by Country in 2024
Figure 24. United States Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2024
Figure 29. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Figure 31. China Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2024
Figure 38. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. APAC Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. Europe Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. United States Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Canada Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. China Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Japan Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Korea Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. India Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Australia Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Germany Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. France Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. UK Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Italy Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Russia Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Israel Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 1. Infectious Diseases Molecular Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Infectious Diseases Molecular Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Infectious Diseases Molecular Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Infectious Diseases Molecular Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Type in 2024
Figure 10. Infectious Diseases Molecular Diagnostics in Hospital
Figure 11. Global Infectious Diseases Molecular Diagnostics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Infectious Diseases Molecular Diagnostics in Third-party Testing Agency
Figure 13. Global Infectious Diseases Molecular Diagnostics Market: Third-party Testing Agency (2020-2025) & ($ millions)
Figure 14. Infectious Diseases Molecular Diagnostics in Others
Figure 15. Global Infectious Diseases Molecular Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Application in 2024
Figure 17. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Player in 2024
Figure 18. Global Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Infectious Diseases Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. APAC Infectious Diseases Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Europe Infectious Diseases Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Americas Infectious Diseases Molecular Diagnostics Value Market Share by Country in 2024
Figure 24. United States Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Region in 2024
Figure 29. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Figure 31. China Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Country in 2024
Figure 38. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Infectious Diseases Molecular Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. APAC Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. Europe Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. United States Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Canada Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. China Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Japan Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Korea Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. India Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Australia Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Germany Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. France Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. UK Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Italy Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Russia Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Israel Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Infectious Diseases Molecular Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Infectious Diseases Molecular Diagnostics Market Size 2026-2031 ($ millions)
More Publications
Global High Volume Dispensing Systems Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
February 2024
90 pages
Global Triptorelin Drug Market Growth 2025-2031
US$ 3,660.00
October 2025
94 pages
Global Hemodialysis Solutions Market Growth 2025-2031
US$ 3,660.00
January 2025
134 pages
Global Thermoformed and Custom Mouthguard Market Growth 2023-2029
US$ 3,660.00
February 2023
108 pages
